Ingredient science · updated 27 October 2026

Huperzine A: The Ingredient That Deserves the Most Caution

It is the only component of this formula with a prescription-drug mechanism — and its dose is hidden inside a blend.

Huperzine A is an alkaloid extracted from Huperzia serrata, a firmoss used in Chinese medicine. It is also an acetylcholinesterase inhibitor, which places it in the same pharmacological class as drugs prescribed for Alzheimer’s disease. That makes it the most consequential ingredient in EyeFortin and the one a careful buyer should understand before starting.

What it does

It inhibits the enzyme that breaks down acetylcholine, raising acetylcholine at synapses throughout the nervous system. The effects are broad: improved cholinergic signalling in the brain, increased parasympathetic tone, and effects on neuromuscular transmission.

The eye research

Two lines of work. Animal and small human studies suggest huperzine A can lower intraocular pressure through muscarinic receptors, and separate work reports retinal neuroprotective effects in experimental models. Cognitive research is more extensive but concerns dementia rather than vision.

None of that constitutes evidence that an undisclosed dose in a supplement improves vision in healthy adults.

The dose problem

Listed as “Huperzine A 1% (Huperzia serrata) (whole herb)” inside a 500 mg blend. That formulation implies a 1% extract, so the alkaloid content depends entirely on how much extract is present — possibly 0.6 mg, possibly 0.05 mg.

Cognitive studies often use 200–400 mcg per day. So the plausible range here straddles the effective range, which is exactly the situation in which an undisclosed dose is unacceptable for anyone with an interaction risk.

Interactions and cautions

The most important section on this page. Huperzine A amplifies cholinergic signalling and can interact with:

  • Cholinesterase inhibitors: donepezil, rivastigmine, galantamine
  • Certain glaucoma medications
  • Anticholinergic drugs, which it opposes
  • Anaesthetic agents — tell your anaesthetist before surgery
  • Bradycardia-inducing drugs

Reported side effects at higher doses include nausea, vomiting, diarrhoea, cramping, sweating, blurred vision and slowed heart rate. It is not appropriate in pregnancy, for children, or for anyone with significant heart, liver or seizure history without medical advice.

The bottom line on huperzine A in EyeFortin

A pharmacologically active ingredient in an unquantified dose, sold inside a formula marketed as suitable for all ages. For healthy adults taking no medication, the risk is small. For anyone on cholinergic or cardiovascular drugs, it is the reason to consult a pharmacist before ordering.

See the side effects page for the fuller interaction checklist, and the safety page for populations to avoid.

Frequently asked questions
Is huperzine A safe?
For healthy adults at low doses, generally. It is an acetylcholinesterase inhibitor with real interaction potential, so anyone on medication should check first.
How much huperzine A is in EyeFortin?
Not disclosed. The label lists a 1% extract inside a 500 mg blend, so the alkaloid content could plausibly range from a fraction of a milligram to about 0.6 mg.
Does huperzine A improve memory?
It has been studied for cognitive decline with mixed results. That is a different question from vision, and this product does not claim it.
Can I take huperzine A with donepezil?
No. Combining them compounds cholinergic effects and risk. This requires medical supervision.

References

  1. Wang R, Tang XC. Neuroprotective effects of huperzine A: a natural cholinesterase inhibitor for the treatment of Alzheimer’s disease. Neurosignals. 2005;14(1–2):71–82. Source
  2. Yu P, Dong WP, Tang YB, et al. Huperzine A lowers intraocular pressure via the M3 mAChR and provides retinal neuroprotection via the M1 mAChR. Annals of Translational Medicine. 2021;9(4):332. Source
  3. National Eye Institute. Glaucoma. Source

Links open in a new tab. Citations are provided for ingredient and background research only. No published trial has tested the finished EyeFortin formula.